MovDisordV3, PascalFrancis, Curation, bibRecord, 002362

Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders

Identifieur interne : 002362 ( PascalFrancis/Curation ); précédent : 002361; suivant : 002363

Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders

Auteurs : Constance Flamand-Rouviere [France] ; Emilie Guettard [France] ; Caroline Moreau [France] ; Nadia Bahi-Buisson [France] ; Vassili Valayannopoulos [France] ; David Grabli [France] ; Jacques Motte [France] ; Diana Rodriguez [France] ; Agathe Roubertie [France] ; Lisa Maintigneux [France] ; Isabelle Kemlin [France] ; Irène Ceballos-Picot [France] ; David Adams [France] ; Marie Vidailhet [France] ; Emmanuel Roze [France]

Source :

Movement disorders [ 0885-3185 ] ; 2010.

RBID : Pascal:10-0413281

Descripteurs français

Pascal (Inist)
- Dystonie, Syndrome choréique, Pathologie du système nerveux, Parole, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Chorea, Dystonia, Human, Nervous system diseases, Speech.

Abstract

Speech disturbances are frequent and potentially disabling in patients with dystonia or chorea due to neurometabolic disorders (DCND), but their precise characteristics are poorly documented. We prospectively studied 29 consecutive patients with DCND. A detailed description of their speech patterns was obtained by using the Frenchay dysarthria assessment test and the apraxia of speech evaluation test of Wertz. Gross motor function and intelligibility were each scored on 5-point scales to identify a possible correlation between the severity of the speech and motor disorders. All the patients were found to have complex speech alterations with combined features of hyperkinetic dysarthria and speech apraxia. We also noted a correlation between the severity of the speech disorders and the motor disorders. These findings have important implications for speech rehabilitation, and may provide new insights into the pathophysiology of dystonia due to neurometabolic disorders.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 25`
A06				`@2 11`
A08	`01`	`1`	`ENG`	`@1 Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders`
A11	`01`	`1`		`@1 FLAMAND-ROUVIERE (Constance)`
A11	`02`	`1`		`@1 GUETTARD (Emilie)`
A11	`03`	`1`		`@1 MOREAU (Caroline)`
A11	`04`	`1`		`@1 BAHI-BUISSON (Nadia)`
A11	`05`	`1`		`@1 VALAYANNOPOULOS (Vassili)`
A11	`06`	`1`		`@1 GRABLI (David)`
A11	`07`	`1`		`@1 MOTTE (Jacques)`
A11	`08`	`1`		`@1 RODRIGUEZ (Diana)`
A11	`09`	`1`		`@1 ROUBERTIE (Agathe)`
A11	`10`	`1`		`@1 MAINTIGNEUX (Lisa)`
A11	`11`	`1`		`@1 KEMLIN (Isabelle)`
A11	`12`	`1`		`@1 CEBALLOS-PICOT (Irène)`
A11	`13`	`1`		`@1 ADAMS (David)`
A11	`14`	`1`		`@1 VIDAILHET (Marie)`
A11	`15`	`1`		`@1 ROZE (Emmanuel)`
A14	`01`			`@1 Service de Neurologie, CHU de Bicêtre, AP-HP @2 Le Kremlin Bicêtre @3 FRA @Z 1 aut. @Z 10 aut. @Z 13 aut.`
A14	`02`			`@1 Service de médecine physique et de réadaptation, Hôpital Fernand Widal, AP-HP @2 Paris @3 FRA @Z 2 aut.`
A14	`03`			`@1 Service de neurologie et pathologie du mouvement, IMPRT, Lille EA 2683, IFR 114 @3 FRA @Z 3 aut.`
A14	`04`			`@1 Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP @2 Paris @3 FRA @Z 4 aut. @Z 5 aut.`
A14	`05`			`@1 Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique @3 FRA @Z 4 aut. @Z 15 aut.`
A14	`06`			`@1 Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker Enfants Malades, Université Paris-Descartes @2 Paris @3 FRA @Z 5 aut.`
A14	`07`			`@1 Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP @2 Paris @3 FRA @Z 6 aut. @Z 14 aut. @Z 15 aut.`
A14	`08`			`@1 Unité de neurologie pédiatrique, American Memorial Hospital, CHU Reims @3 FRA @Z 7 aut.`
A14	`09`			`@1 Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP @2 Paris @3 FRA @Z 8 aut. @Z 11 aut.`
A14	`10`			`@1 Service de Neurologie Pédiatrique, CHU @2 Montpellier @3 FRA @Z 9 aut.`
A14	`11`			`@1 Service de Biochimie Métabolique, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP @2 Paris @3 FRA @Z 12 aut.`
A14	`12`			`@1 Centre d'Investigation Clinique, 9503, INSERM, AP-HP @2 Paris @3 FRA @Z 15 aut.`
A14	`13`			`@1 CNRS UMRS 952, INSERM UMR 7224, Université Pierre et Marie Curie Paris VI @2 Paris @3 FRA @Z 15 aut.`
A20				`@1 1605-1611`
A21				`@1 2010`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000192608100110`
A44				`@0 0000 @1 © 2010 INIST-CNRS. All rights reserved.`
A45				`@0 35 ref.`
A47	`01`	`1`		`@0 10-0413281`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Speech disturbances are frequent and potentially disabling in patients with dystonia or chorea due to neurometabolic disorders (DCND), but their precise characteristics are poorly documented. We prospectively studied 29 consecutive patients with DCND. A detailed description of their speech patterns was obtained by using the Frenchay dysarthria assessment test and the apraxia of speech evaluation test of Wertz. Gross motor function and intelligibility were each scored on 5-point scales to identify a possible correlation between the severity of the speech and motor disorders. All the patients were found to have complex speech alterations with combined features of hyperkinetic dysarthria and speech apraxia. We also noted a correlation between the severity of the speech disorders and the motor disorders. These findings have important implications for speech rehabilitation, and may provide new insights into the pathophysiology of dystonia due to neurometabolic disorders.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17H`
C03	`01`	`X`	`FRE`	`@0 Dystonie @5 01`
C03	`01`	`X`	`ENG`	`@0 Dystonia @5 01`
C03	`01`	`X`	`SPA`	`@0 Distonía @5 01`
C03	`02`	`X`	`FRE`	`@0 Syndrome choréique @5 02`
C03	`02`	`X`	`ENG`	`@0 Chorea @5 02`
C03	`02`	`X`	`SPA`	`@0 Corea síndrome @5 02`
C03	`03`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 03`
C03	`03`	`X`	`ENG`	`@0 Nervous system diseases @5 03`
C03	`03`	`X`	`SPA`	`@0 Sistema nervioso patología @5 03`
C03	`04`	`X`	`FRE`	`@0 Parole @5 09`
C03	`04`	`X`	`ENG`	`@0 Speech @5 09`
C03	`04`	`X`	`SPA`	`@0 Habla @5 09`
C03	`05`	`X`	`FRE`	`@0 Homme @5 10`
C03	`05`	`X`	`ENG`	`@0 Human @5 10`
C03	`05`	`X`	`SPA`	`@0 Hombre @5 10`
C07	`01`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 37`
C07	`01`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 37`
C07	`01`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 37`
C07	`02`	`X`	`FRE`	`@0 Mouvement involontaire @5 38`
C07	`02`	`X`	`ENG`	`@0 Involuntary movement @5 38`
C07	`02`	`X`	`SPA`	`@0 Movimiento involuntario @5 38`
C07	`03`	`X`	`FRE`	`@0 Pathologie du muscle strié @5 39`
C07	`03`	`X`	`ENG`	`@0 Striated muscle disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Músculo estriado patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Trouble neurologique @5 41`
C07	`04`	`X`	`ENG`	`@0 Neurological disorder @5 41`
C07	`04`	`X`	`SPA`	`@0 Trastorno neurológico @5 41`
C07	`05`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 42`
C07	`05`	`X`	`ENG`	`@0 Cerebral disorder @5 42`
C07	`05`	`X`	`SPA`	`@0 Encéfalo patología @5 42`
C07	`06`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 43`
C07	`06`	`X`	`ENG`	`@0 Central nervous system disease @5 43`
C07	`06`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 43`
N21				`@1 270`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000957

Links to Exploration step

Pascal:10-0413281

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders</title>
<author><name sortKey="Flamand Rouviere, Constance" sort="Flamand Rouviere, Constance" uniqKey="Flamand Rouviere C" first="Constance" last="Flamand-Rouviere">Constance Flamand-Rouviere</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Guettard, Emilie" sort="Guettard, Emilie" uniqKey="Guettard E" first="Emilie" last="Guettard">Emilie Guettard</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de médecine physique et de réadaptation, Hôpital Fernand Widal, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Moreau, Caroline" sort="Moreau, Caroline" uniqKey="Moreau C" first="Caroline" last="Moreau">Caroline Moreau</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Service de neurologie et pathologie du mouvement, IMPRT, Lille EA 2683, IFR 114</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Bahi Buisson, Nadia" sort="Bahi Buisson, Nadia" uniqKey="Bahi Buisson N" first="Nadia" last="Bahi-Buisson">Nadia Bahi-Buisson</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Valayannopoulos, Vassili" sort="Valayannopoulos, Vassili" uniqKey="Valayannopoulos V" first="Vassili" last="Valayannopoulos">Vassili Valayannopoulos</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker Enfants Malades, Université Paris-Descartes</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Grabli, David" sort="Grabli, David" uniqKey="Grabli D" first="David" last="Grabli">David Grabli</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Motte, Jacques" sort="Motte, Jacques" uniqKey="Motte J" first="Jacques" last="Motte">Jacques Motte</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Unité de neurologie pédiatrique, American Memorial Hospital, CHU Reims</s1>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Rodriguez, Diana" sort="Rodriguez, Diana" uniqKey="Rodriguez D" first="Diana" last="Rodriguez">Diana Rodriguez</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Roubertie, Agathe" sort="Roubertie, Agathe" uniqKey="Roubertie A" first="Agathe" last="Roubertie">Agathe Roubertie</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Service de Neurologie Pédiatrique, CHU</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Maintigneux, Lisa" sort="Maintigneux, Lisa" uniqKey="Maintigneux L" first="Lisa" last="Maintigneux">Lisa Maintigneux</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Kemlin, Isabelle" sort="Kemlin, Isabelle" uniqKey="Kemlin I" first="Isabelle" last="Kemlin">Isabelle Kemlin</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Ceballos Picot, Irene" sort="Ceballos Picot, Irene" uniqKey="Ceballos Picot I" first="Irène" last="Ceballos-Picot">Irène Ceballos-Picot</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Service de Biochimie Métabolique, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Adams, David" sort="Adams, David" uniqKey="Adams D" first="David" last="Adams">David Adams</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Roze, Emmanuel" sort="Roze, Emmanuel" uniqKey="Roze E" first="Emmanuel" last="Roze">Emmanuel Roze</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Centre d'Investigation Clinique, 9503, INSERM, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>CNRS UMRS 952, INSERM UMR 7224, Université Pierre et Marie Curie Paris VI</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0413281</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0413281 INIST</idno>
<idno type="RBID">Pascal:10-0413281</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000957</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002362</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders</title>
<author><name sortKey="Flamand Rouviere, Constance" sort="Flamand Rouviere, Constance" uniqKey="Flamand Rouviere C" first="Constance" last="Flamand-Rouviere">Constance Flamand-Rouviere</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Guettard, Emilie" sort="Guettard, Emilie" uniqKey="Guettard E" first="Emilie" last="Guettard">Emilie Guettard</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de médecine physique et de réadaptation, Hôpital Fernand Widal, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Moreau, Caroline" sort="Moreau, Caroline" uniqKey="Moreau C" first="Caroline" last="Moreau">Caroline Moreau</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Service de neurologie et pathologie du mouvement, IMPRT, Lille EA 2683, IFR 114</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Bahi Buisson, Nadia" sort="Bahi Buisson, Nadia" uniqKey="Bahi Buisson N" first="Nadia" last="Bahi-Buisson">Nadia Bahi-Buisson</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Valayannopoulos, Vassili" sort="Valayannopoulos, Vassili" uniqKey="Valayannopoulos V" first="Vassili" last="Valayannopoulos">Vassili Valayannopoulos</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker Enfants Malades, Université Paris-Descartes</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Grabli, David" sort="Grabli, David" uniqKey="Grabli D" first="David" last="Grabli">David Grabli</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Motte, Jacques" sort="Motte, Jacques" uniqKey="Motte J" first="Jacques" last="Motte">Jacques Motte</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Unité de neurologie pédiatrique, American Memorial Hospital, CHU Reims</s1>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Rodriguez, Diana" sort="Rodriguez, Diana" uniqKey="Rodriguez D" first="Diana" last="Rodriguez">Diana Rodriguez</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Roubertie, Agathe" sort="Roubertie, Agathe" uniqKey="Roubertie A" first="Agathe" last="Roubertie">Agathe Roubertie</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Service de Neurologie Pédiatrique, CHU</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Maintigneux, Lisa" sort="Maintigneux, Lisa" uniqKey="Maintigneux L" first="Lisa" last="Maintigneux">Lisa Maintigneux</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Kemlin, Isabelle" sort="Kemlin, Isabelle" uniqKey="Kemlin I" first="Isabelle" last="Kemlin">Isabelle Kemlin</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Ceballos Picot, Irene" sort="Ceballos Picot, Irene" uniqKey="Ceballos Picot I" first="Irène" last="Ceballos-Picot">Irène Ceballos-Picot</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Service de Biochimie Métabolique, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Adams, David" sort="Adams, David" uniqKey="Adams D" first="David" last="Adams">David Adams</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Roze, Emmanuel" sort="Roze, Emmanuel" uniqKey="Roze E" first="Emmanuel" last="Roze">Emmanuel Roze</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Centre d'Investigation Clinique, 9503, INSERM, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>CNRS UMRS 952, INSERM UMR 7224, Université Pierre et Marie Curie Paris VI</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chorea</term>
<term>Dystonia</term>
<term>Human</term>
<term>Nervous system diseases</term>
<term>Speech</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Dystonie</term>
<term>Syndrome choréique</term>
<term>Pathologie du   système nerveux</term>
<term>Parole</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Speech disturbances are frequent and potentially disabling in patients with dystonia or chorea due to neurometabolic disorders (DCND), but their precise characteristics are poorly documented. We prospectively studied 29 consecutive patients with DCND. A detailed description of their speech patterns was obtained by using the Frenchay dysarthria assessment test and the apraxia of speech evaluation test of Wertz. Gross motor function and intelligibility were each scored on 5-point scales to identify a possible correlation between the severity of the speech and motor disorders. All the patients were found to have complex speech alterations with combined features of hyperkinetic dysarthria and speech apraxia. We also noted a correlation between the severity of the speech disorders and the motor disorders. These findings have important implications for speech rehabilitation, and may provide new insights into the pathophysiology of dystonia due to neurometabolic disorders.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>25</s2>
</fA05>
<fA06><s2>11</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>FLAMAND-ROUVIERE (Constance)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>GUETTARD (Emilie)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>MOREAU (Caroline)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>BAHI-BUISSON (Nadia)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>VALAYANNOPOULOS (Vassili)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>GRABLI (David)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>MOTTE (Jacques)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>RODRIGUEZ (Diana)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>ROUBERTIE (Agathe)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>MAINTIGNEUX (Lisa)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>KEMLIN (Isabelle)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>CEBALLOS-PICOT (Irène)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>ADAMS (David)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>VIDAILHET (Marie)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>ROZE (Emmanuel)</s1>
</fA11>
<fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Service de médecine physique et de réadaptation, Hôpital Fernand Widal, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Service de neurologie et pathologie du mouvement, IMPRT, Lille EA 2683, IFR 114</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker Enfants Malades, Université Paris-Descartes</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Unité de neurologie pédiatrique, American Memorial Hospital, CHU Reims</s1>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Service de Neurologie Pédiatrique, CHU</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>Service de Biochimie Métabolique, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>Centre d'Investigation Clinique, 9503, INSERM, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="13"><s1>CNRS UMRS 952, INSERM UMR 7224, Université Pierre et Marie Curie Paris VI</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</fA14>
<fA20><s1>1605-1611</s1>
</fA20>
<fA21><s1>2010</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000192608100110</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>35 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>10-0413281</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Speech disturbances are frequent and potentially disabling in patients with dystonia or chorea due to neurometabolic disorders (DCND), but their precise characteristics are poorly documented. We prospectively studied 29 consecutive patients with DCND. A detailed description of their speech patterns was obtained by using the Frenchay dysarthria assessment test and the apraxia of speech evaluation test of Wertz. Gross motor function and intelligibility were each scored on 5-point scales to identify a possible correlation between the severity of the speech and motor disorders. All the patients were found to have complex speech alterations with combined features of hyperkinetic dysarthria and speech apraxia. We also noted a correlation between the severity of the speech disorders and the motor disorders. These findings have important implications for speech rehabilitation, and may provide new insights into the pathophysiology of dystonia due to neurometabolic disorders.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17H</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Dystonie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Dystonia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Distonía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Syndrome choréique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Chorea</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Corea síndrome</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Parole</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Speech</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Habla</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Homme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Human</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Hombre</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie du muscle strié</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Striated muscle disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Músculo estriado patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>43</s5>
</fC07>
<fN21><s1>270</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002362 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 002362 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:10-0413281
   |texte=   Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders

Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri